Central Nervous System Stimulants and Drugs That Suppress Appetite

Matthew R. Zahner, Nicholas T. Bello

Research output: Chapter in Book/Report/Conference proceedingChapter


The Side Effects of Drugs Annuals form a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. This is a review of the January 2015 to December 2015 publications on central nervous system stimulants and drugs that suppress appetite. It covers amphetamines (including lisdexamfetamine, methamphetamine and 3,4-methylenedioxymethamphetamine), methylphenidate, atomoxetine, modafinil and armodafinil, methylxanthines (caffeine), monotherapies and combinational therapies that suppress appetite (lorcaserin, phentermine, phentermine/topiramate) and medications used in Alzheimer's disease and cognitive decline (rivastigmine, donepezil and galantamine).

Original languageEnglish (US)
Title of host publicationSide Effects of Drugs Annual
PublisherElsevier B.V.
Number of pages10
StatePublished - 2016

Publication series

NameSide Effects of Drugs Annual
ISSN (Print)0378-6080

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug guides
  • Pharmacology (medical)


  • Adverse reactions
  • Alzheimer's disease
  • Amphetamines
  • Appetite suppressants
  • Armodafinil
  • Atomoxetine
  • Caffeine
  • Donepezil
  • Galantamine
  • Lisdexamfetamine
  • Lorcaserin
  • Methylphenidate
  • Methylxanthines
  • Modafinil
  • Phentermine
  • Qsymia
  • Rivastigmine
  • Treatment-emergent adverse effects


Dive into the research topics of 'Central Nervous System Stimulants and Drugs That Suppress Appetite'. Together they form a unique fingerprint.

Cite this